Skip to main content
Download PDF
Download ePub

The association between cardiovascular health and cognition in adults with Down syndrome

Journal of Neurodevelopmental Disorders volume 15, Article number: 43 (2023) Cite this article

Abstract

Introduction

Evidence in the general population suggests that predictors of cardiovascular health such as moderate to vigorous physical activity (MVPA), cardiorespiratory fitness, and systolic blood pressure are associated with cognitive function. Studies supporting these associations in adults with Down syndrome (DS) are limited. The purpose of this study was to examine the associations between systolic blood pressure, cardiorespiratory fitness, and MVPA on cognition in adults with DS.

Methods

This is a cross-sectional analysis using baseline data from a trial in adults with DS. Participants attended a laboratory visit where resting blood pressure, cardiorespiratory fitness (VO2 Peak), and cognitive function (CANTAB® DS Battery) were obtained. The cognitive battery included tests measuring multitasking, episodic memory, and reaction time. Physical activity (accelerometer) was collected over the week following the laboratory visit. Pearson correlations and linear regressions were used to measure the impact of systolic blood pressure, cardiorespiratory fitness, and MVPA on cognitive outcomes.

Results

Complete data was available for 72 adults with DS (26.8 ± 9.3 years of age, 57% female). At baseline, VO2 Peak (21.1 ± 4.2 ml/kg/min) and MVPA were low (14.4 ± 14.4 min/day), and systolic blood pressure was 118.3 ± 13.3 mmHg. VO2 Peak was correlated with simple movement time (rho =  − 0.28, p = 0.03) but was not significant using a linear regression controlling for age and sex. Systolic blood pressure was significantly associated with episodic memory (first attempt memory score: β =  − 0.11, p = 0.002; total errors: β = 0.58, p = 0.001) and reaction time (five-choice movement time: β = 4.11, p = 0.03; simple movement time: β = 6.14, p = 0.005) using age- and sex-adjusted linear regressions. No associations were observed between MVPA and multitasking, episodic memory, or reaction time.

Conclusion

Predictors of cardiovascular health, including cardiorespiratory fitness and systolic blood pressure, were associated with some aspects of cognition in adults with DS. While future research should examine the role of improved cardiovascular health on delaying decreases in cognitive function and dementia in adults with DS, we recommend that health care providers convey the importance of exercise and cardiovascular health to their patients with DS.

Trial registration

NCT04048759, registered on August 7, 2019.

Introduction

Down syndrome (DS) is a genetic condition caused by extra chromosome 21 material in all or some cells of the body and is the most common chromosomal abnormality associated with an intellectual disability [1]. The current incidence of DS is 1 in every 650 live births [2]. The life expectancy for individuals with DS has increased dramatically in recent decades from 4 years in the 1970s due to high rates of congenital heart defects, to 60 years currently [3].

However, with this increase in life expectancy comes an increased risk of Alzheimer’s disease (AD) and dementia. By the age of 65 years, the cumulative incidence of dementia exceeds 90% [4] and is the leading cause of death in individuals with DS [5]. Adults with DS also have an earlier onset of dementia with cognitive declines starting at ~ 40 years of age [4, 5]. Research in midlife adults without DS suggests that factors related to cardiovascular health such as increased moderate-to-vigorous physical activity (MVPA), cardiorespiratory fitness, and systolic blood pressure are associated with components of cognition including attention, memory, and executive function [6,7,8]. Additionally, MVPA [9] cardiorespiratory fitness [10] and systolic blood pressure [11] at midlife are associated with a lower incidence of later life dementia, possibly by increasing cognitive reserve so that a person can better maintain cognitive performance even with neuropathologic changes related to AD [12].

Previous research in adults with DS suggests that MVPA may be associated with cognitive function [13, 14]. However, we are unaware of previous studies that have examined the association of systolic blood pressure and cardiorespiratory fitness on cognition in adults with DS without dementia. Thus, this project aims to use baseline data collected from a physical activity trial in adults with DS to examine the association of systolic blood pressure, cardiorespiratory fitness, and MVPA on cognition in adults with DS.

Methods

Overview

This is a cross-sectional analysis using baseline data from a physical activity trial in adults with DS without dementia [15]. Participants attended a single laboratory visit for assessments of resting blood pressure, cardiorespiratory fitness, and cognition, then wore an accelerometer belt to assess MVPA for 7 days following the laboratory visit. All data were collected between January 2020 and November 2022. This study was approved by the University’s Institutional Review Board. Informed consent and assent were obtained from participants and their parent/legal guardians prior to data collection.

Participants

Participants were adults (≥ 18 years of age) with DS who were living at home with a parent or guardian or in a supported living environment with a caregiver who agreed to serve as a study partner. Additional inclusion criteria were mild to moderate intellectual disabilities, sufficient functional ability to understand directions, ability to communicate through spoken language, ability to participate in physical activity, and walk 10 feet unassisted and having Internet access in the home. Participants were excluded if they had dementia as determined by the Dementia Screening Questionnaire for Individuals with Intellectual Disabilities (DSQIID) [16]; participated in a regular exercise program (i.e., ≥ 20 min/days ≥ 3 days/weeks); had a serious medical risk, such as cancer or a recent cardiac event as assessed by the primary health care provider; or were unable to participate in MVPA. Participants were recruited using flyers, list-serves, and social media posts by local organizations that provide services to adults with DS (e.g., Down syndrome societies, day service programs, and clinics and community developmental disability organizations funded by Medicare). Participants could be living with a family member, alone or with roommates, or in a supported group living environment. Caregivers of potential participants were asked to contact the study coordinator who answered questions about the study and administered the initial participant eligibility screener which included questions about the participants’ functional ability, communication skills, and the DSQIID. A home visit or video conference meeting was scheduled with those remaining interested and potentially eligible to determine final eligibility and to obtain consent.

Outcomes

Resting blood pressure was measured on the non-dominant arm with participants seated in a chair and both feet flat on the ground. An aerobic step was placed under the feet of those participants who were unable to place their feet on the ground. After 5 min of quiet rest in a chair, blood pressure was taken in duplicate with 2 min separating the first and second measurements. A third measurement was taken for systolic and diastolic values ≥ 5 mmHg apart, and the average of the two closest measures was used for analysis. Systolic blood pressure represents the amount of pressure exerted by blood against your artery walls during ventricular contraction, whereas diastolic blood pressure is the amount of pressure exerted against your artery walls during ventricular rest between contractions. Only systolic blood pressure was used as an outcome since it is a better predictor of cardiovascular outcomes in midlife [17, 18].

Cardiorespiratory fitness (VO2 Peak) measured in ml/kg/min was assessed using a maximal treadmill test, following the protocol described by Fernhall et al. developed for adults with DS [19]. Expired O2 and CO2 were measured using indirect calorimetry (ParvoMedics TrueOne 2300, Salt Lake City, Utah), which was calibrated with known volume and gas concentrations prior to each test according to the manufacturer’s recommendations. Values were averaged over 15-s intervals across the treadmill protocol. The exercise test was terminated if participants were unable to maintain the treadmill speed or requested that the test be stopped at any time during the treadmill protocol. Otherwise, tests were terminated when participants achieved two or more of the following criteria: (1) volitional exhaustion; (2) a plateau in VO2, i.e., < 150 ml/min or heart rate (HR) < 2 beats/min with increased work rate; (3) a HR within 5 beats/min of HRPeak predicted using the formula of Fernhall et al. [19]; and (4) a respiratory exchange ratio ≥ 1.0. Only participants who achieved a respiratory exchange ratio ≥ 1.0 or had a HR within 10 beats/min of their HRPeak were included in the analysis.

Physical activity

MVPA and sedentary time were assessed using an ActiGraph wGT3XBT tri-axial accelerometer (ActiGraph LLC, Pensacola, FL) worn on the non-dominant hip at the anterior axillary line during waking hours for 7 consecutive days. Vertical axis data aggregated over 60 s epochs from the ActiGraph devices were initialized and downloaded using Actilife software version 6.13.3 (ActiGraph LLC, Pensacola, FL). Non-wear time was defined as at least 90 consecutive minutes of zero counts, with an allowance for 1–2 min of movement between zero and 100 counts/min [20]. Counts ≥ 20,000·min−1 were considered spurious [21]. A wear time ≥ 8 h on at least 3 days including 1 weekend day was required for inclusion in the analysis. Vertical axis ActiGraph cut points used for adults in the 2003–2004 and 2005–2006 cycles of NHANES were used to classify minutes of sedentary time (< 1.0 MET, ≤ 100 counts/min) and MVPA (≥ 3 METs, ≥ 2020 counts/min) [22, 23].

Cognitive function was assessed using the Cambridge Neuropsychological Test Automated Battery for DS (CANTAB®, Cambridge Cognition, LTD, Cambridge, UK) [24, 25] administered on an iPad® in a quiet room. The CANTAB® DS Battery, which has been used in previous trials in individuals with DS [26, 27], includes measures of executive function, episodic memory, and processing speed. CANTAB® DS Battery measures have demonstrated sensitivity to disease-specific cognitive deficits in DS, including those related to hippocampal dysfunction, and sensitivity to changes in cognitive function associated with AD [28]. The following CANTAB tests were used:

Multitasking task

Multitasking task, a measurement of executive function, assessed the ability of participants to ignore task-irrelevant information. An arrow was presented on either side of the screen pointing in either direction (right or left). Participants had to pay attention to either the side of the screen where the arrow appears or the direction of the arrow (indicated by SIDE or DIRECTION on the screen), by pressing a button on the left or right corner of the screen, respectively. Four key outcomes were collected from the multitasking task: incongruency cost, which is the difference (in milliseconds) between the median latency of response (from stimulus appearance to button press) on the trials that were congruent versus the trials that were incongruent; reaction latency, which is the median latency of response (from stimulus appearance to button press); multitasking cost, which is the difference (seconds) between the median latency of response (from stimulus appearance to button press) during assessed blocks in which both rules are used versus assessed blocks in which only a single rule is used; and total incorrect, which is the number of trials for which the outcome was an incorrect response.

Episodic memory

The paired associates learning test assessed visual episodic memory. Participants were presented with boxes on the screen in which different visual patterns are shown one by one. After the encoding phase, the different patterns were shown in the middle of the screen and participants had to select the box in which the pattern was previously presented. Outcome measures included the first attempt memory score, which assessed the number of times a participant was able to correctly recall a pattern previously displayed on the computer screen on their first attempt with higher scores indicating better memory, and the total errors, which are the number of times the subject chose the incorrect box for a stimulus on assessment problems plus an adjustment for the estimated number of errors they would have made on any problems, attempts, and recalls they did not reach.

Reaction time

The reaction time task, a measure of attention and psychomotor speed, assessed reaction times for motor and mental responses. Previous research suggests that simple reaction time is correlated to memory and verbal fluency, and choice reaction time is related to language, orientation, and verbal fluency [29,30,31]. During the task, circles (one for the simple task and five for the choice mode) were shown at the top of the screen in which a random yellow light appeared. Participants had to hold a button on the bottom of the screen and release it to select the circle above in which they detected the yellow light as fast as possible and then return their fingers to the hold button. Outcome measures included simple and five-choice reaction time, which is the medium duration required for participants to release the response button following presentation of the target stimulus (milliseconds) calculated across trials when the stimulus could appear in only one location or in any one of five locations, respectively, and simple and five-choice movement time, which is the median time (milliseconds) taken for a subject to release the response button and select the target stimulus after it flashed yellow on screen, calculated across trials when the stimulus could appear in only one location or in any one of five locations.

Statistical analysis

Sample characteristics were described as mean ± standard deviation or frequency (percentage) for demographic (i.e., age, race, ethnicity, level of support), anthropometric (i.e., height, weight, body mass index), systolic and diastolic blood pressure, and cardiorespiratory fitness (VO2 Peak) measures. Pearson correlations were used to describe the association between (1) systolic blood pressure, (2) cardiorespiratory fitness, and (3) MVPA with 10 cognition measures within 3 domains (i.e., multitasking cost, episodic memory, and reaction time). Linear regressions were used to further explore the impact of systolic blood pressure, cardiorespiratory fitness, and MVPA on cognition in adults with DS while adjusting for age, sex, and body mass index. R version 4.2.2 was used for this analysis [32].

Results

Baseline data were collected from 82 adults with DS, of those 72 completed the full cognitive battery and were included in this analysis. Participants were 26.8 ± 9.3 years of age, 57% female, and ~ 75% were living with a parent. Sample characteristics stratified by sex are presented in Table 1. Pearson correlations between systolic blood pressure, cardiorespiratory fitness, and MVPA and cognitive outcomes are presented in Table 2, and the impact of systolic blood pressure, cardiorespiratory fitness, and MVPA on cognitive outcomes using linear regression is presented in Table 3.

Table 1 Sample characteristics of adults with Down syndrome included in the analysis
Full size table
Table 2 Pearson correlations between factors related to cardiovascular health and cognitive outcomes in adults with Down syndrome
Full size table
Table 3 Examining the association between factors related to cardiovascular health and cognition using linear regression
Full size table

Resting blood pressure was collected from 63 participants. Mean systolic blood pressure was 118.3 ± 13.3 mmHg, and 1 participant met the criteria for hypertension (i.e., ≤ 140/90 mmHg). Systolic blood pressure was significantly correlated with both episodic memory measures (both p ≤ 0.001) and 3 measures of reaction time: five-choice movement time (rho = 0.29, p = 0.02), simple movement time (rho = 0.35, p = 0.005), and simple reaction time (rho = 0.27, p = 0.03). When controlling for age and sex, systolic blood pressure had a significant association with both episodic memory measures, five-choice movement time, and simple movement time (all p < 0.05, Fig. 1). No associations were observed with any of the multitasking measures.

Fig. 1
figure 1

The linear association between systolic blood pressure (mmHg) and cognitive function variables in adults with Down syndrome

Full size image

Cardiorespiratory fitness

Valid cardiorespiratory fitness was obtained from 61 participants, and the mean VO2 Peak was 21.1 ± 4.2 ml/kg/min. Cardiorespiratory fitness was significantly correlated with simple movement time (rho =  − 0.28, p = 0.03). There was no association between VO2 Peak and cognitive outcomes after adjusting for age and sex in a linear regression; however, the crude association between VO2 Peak and simple movement time was statistically significant (β =  − 11.61, p = 0.03, Fig. 2). No associations were observed with multitasking or episodic memory measures.

Fig. 2
figure 2

The linear association between cardiorespiratory fitness (VO2peak) and cognitive function in adults with Down syndrome

Full size image

Moderate to vigorous physical activity

Valid accelerometer data was obtained from 59 participants, and the mean MVPA was 14.4 ± 14.4 min/day. MVPA was not significantly correlated with any of the cognitive measures (all p > 0.05), nor were any associations observed when using linear regression controlling for age and sex.

Discussion

The results of the current study observed an association between systolic blood pressure and episodic memory as well as 2 measures of reaction time. Additionally, we observed a correlation between cardiorespiratory fitness and simple movement time which measured psychomotor speed; however, when controlling for sex and age, this association was no longer significant. Additionally, the current study did not observe an association between MVPA and any of the cognitive measures.

Adults with DS have very low cardiorespiratory fitness [33, 34] and low normal blood pressure [35, 36]. For example, in the current study, cardiorespiratory fitness was ~ 21 ml/kg/min, compared to ~ 34–44 ml/kg/min observed in adults of similar age without DS [37]. Several factors have been proposed to explain the low cardiorespiratory fitness and blood pressure in individuals with DS, with the most likely cause being autonomic dysfunction [33, 34, 38]. Autonomic dysfunction includes lower maximal HR, resulting in lower cardiac output and exercise capacity [33, 39], and impaired blood pressure control and peripheral blood flow regulation, which potentially impairs the person with DS’s ability to direct blood flow to working muscles during exercise [33, 34, 38]. It is unclear how autonomic dysfunction may influence the association between cardiovascular health and cognition in adults with DS; however, the results of the current study suggest that blood pressure and cardiorespiratory fitness may still be associated with some aspects of cognition.

We are unaware of previous research examining the association between systolic blood pressure or cardiorespiratory fitness and cognitive function in adults with DS. In the non-DS population chronic high blood pressure, known as hypertension, is associated with cognitive decline and risk of later life dementia [11, 40]. For example, a recent systemic review and meta-analysis [11] found moderate-quality evidence indicating that midlife hypertension was related to a 1.19 to 1.55-fold excess risk of cognitive disorders. Dose–response analyses of 5 studies included in the review indicated that midlife systolic blood pressure of > 130 mm Hg was associated with a 34% increased risk of dementia. The mechanisms underlying hypertension-related cognitive changes are complex and not yet fully understood [17]. However, it is thought that hypertension causes oxidative stress and inflammation, which disrupts the blood–brain barrier and leads to white matter lesions [41]. White lesions are thought to affect cognition by impairing the connectivity between the anterior thalamus and the frontal cortex [41]. However, individuals with DS have lower blood pressure compared with age-matched controls [36], and it is believed that individuals with DS may be protected from hypertension [42, 43]. Thus, it was unknown if blood pressure would be associated with cognition in adults with DS. However, the results of the current study found a strong correlation between lower systolic blood pressure and better memory scores and reaction time scores, suggesting that systolic blood pressure may indeed play a role in cognitive function in this population.

The results of the current study found a correlation between cardiorespiratory fitness and simple movement time, although this relationship was no longer significant when controlling for age and sex. We are unaware of any previous research examining the association of cardiorespiratory fitness on cognition in adults with DS. In the non-DS population, cardiorespiratory fitness has been associated with improved reaction time in the general population [44] and in adults with multiple sclerosis [45]. In adults without DS, most research has focused on the relationship between increased cardiorespiratory fitness and episodic memory [46,47,48]. The results of the current study did not observe an association between cardiorespiratory fitness and episodic memory. However, previous work by our group in 27 adults with DS [49] observed improvements in episodic memory (p = 0.048) after 12 weeks of exercise [49], suggesting that exercise, and secondary increases in cardiorespiratory fitness, may be associated with improvements in episodic memory. Future research examining the impact of increased cardiorespiratory fitness on cognition is warranted.

MVPA is thought to impact cognition by multiple pathways, including improving other cardiovascular risk factors (e.g., hypertension, obesity, dyslipidemia) and improving cardiorespiratory fitness (VO2 Peak) [50]. We did not observe any association between MVPA and cognition, which contrasts with previous research in adults with DS suggesting that MVPA is closely associated with cognition [13, 14]. For example, Fleming et al. [13] reported that the percentage of time spent in MVPA was significantly correlated with 8/9 cognitive outcomes used in Alzheimer’s Biomarker Consortium DS (ABC-DS) cognitive battery [51]. Similarly, a study by Pape et al. [14] which followed 214 participants across 12 months observed that higher MVPA at baseline was associated with a 62% reduced risk of decline in memory and orientation at 12 months. Additionally, previous intervention studies in adults with DS have demonstrated the potential for acute or short-term (≤ 12 weeks) MVPA to improve cognitive outcomes [9, 49, 52,53,54]. Trials examining the impact of long-term increases on MVPA on cognition are warranted.

This study benefits from the use of device-based assessments of MVPA and the use of directly measured cardiorespiratory fitness (i.e., VO2 Peak), as well as a relatively large and diverse sample of adults with DS. However, it is limited as the data is cross-sectional and all participants were from a sample of adults with DS who had agreed to participate in a program focused on the promotion of physical activity. One major limitation of the current study is that all participants had low levels of cardiorespiratory fitness (~ 21 ml/kg/min) and MVPA (~ 14 min/day) which was required for inclusion in the clinical trial; therefore, there was a smaller range of MVPA and cardiorespiratory fitness in this sample compared with the general population of individuals with DS, limiting our ability to detect a correlation with cognition. Similarly, participants were younger and cognitively stable; thus, we were unable to examine the cognition of older adults more at risk of dementia or who had already progressed to Alzheimer’s disease.

Conclusion

Cardiovascular risk factors, including low cardiorespiratory fitness and high systolic blood pressure, were associated with some aspects of cognition in adults with DS. While future research should examine the role of improved cardiovascular health on delaying decreases in cognitive function and dementia in adults with DS, we recommend that health care providers convey the importance of exercise and cardiovascular health to their patients with DS, especially given the high prevalence of dementia in adults with DS.

Availability of data and materials

Deidentified individual participant data (including data dictionaries) will be made available, in addition to study protocols, the statistical analysis plan, and the informed consent form. The data will be made available upon publication to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal. Proposals should be submitted to the corresponding author at lptomey@kumc.edu.

Abbreviations

DS:

Down syndrome

AD:

Alzheimer’s disease

MVPA:

Moderate to vigorous physical activity

DSQIID:

Dementia Screening Questionnaire for Individuals with Intellectual Disabilities

References

  1. Bull MJ. Down syndrome. N Engl J Med. 2020;382(24):2344–52.

    Article  PubMed  Google Scholar 

  2. De Graaf G, Buckley F, Skotko BG. Estimation of the number of people with Down syndrome in the United States. Genet Med. 2017;19(4):439.

    Article  PubMed  Google Scholar 

  3. Englund A, Jonsson B, Zander CS, Gustafsson J, Annerén G. Changes in mortality and causes of death in the Swedish Down syndrome population. Am J Med Genet A. 2013;161(4):642–9.

    Article  Google Scholar 

  4. Fortea J, Vilaplana E, Carmona-Iragui M, Benejam B, Videla L, Barroeta I, et al. Clinical and biomarker changes of Alzheimer’s disease in adults with Down syndrome: a cross-sectional study. Lancet. 2020;395(10242):1988–97.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-Iragui M. Alzheimer’s disease associated with Down syndrome: a genetic form of dementia. Lancet Neurology. 2021;20(11):930–42.

    Article  PubMed  CAS  Google Scholar 

  6. Lautenschlager NT, Cox KL, Flicker L, Foster JK, Van Bockxmeer FM, Xiao J, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA. 2008;300(9):1027–37.

    Article  PubMed  CAS  Google Scholar 

  7. Bherer L, Erickson KI, Liu-Ambrose T. A review of the effects of physical activity and exercise on cognitive and brain functions in older adults. J Aging Res. 2013;2013.

  8. España-Irla G, Gomes-Osman J, Cattaneo G, Albu S, Cabello-Toscano M, Solana-Sanchéz J, et al. Associations between cardiorespiratory fitness, cardiovascular risk, and cognition are mediated by structural brain health in midlife. J Am Heart Assoc. 2021;10(18):e020688.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Nianogo RA, Rosenwohl-Mack A, Yaffe K, Carrasco A, Hoffmann CM, Barnes DE. Risk factors associated with Alzheimer disease and related dementias by sex and race and ethnicity in the US. JAMA Neurol. 2022;79(6):584–91.

    Article  PubMed  PubMed Central  Google Scholar 

  10. DeFina LF, Willis BL, Radford NB, Gao A, Leonard D, Haskell WL, et al. The association between midlife cardiorespiratory fitness levels and later-life dementia: a cohort study. Ann Intern Med. 2013;158(3):162–8.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ou Y-N, Tan C-C, Shen X-N, Xu W, Hou X-H, Dong Q, et al. Blood pressure and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 209 prospective studies. Hypertension. 2020;76(1):217–25.

    Article  PubMed  CAS  Google Scholar 

  12. Whalley LJ, Deary IJ, Appleton CL, Starr JM. Cognitive reserve and the neurobiology of cognitive aging. Ageing Res Rev. 2004;3(4):369–82.

    Article  PubMed  Google Scholar 

  13. Fleming V, Piro-Gambetti B, Patrick A, Zammit M, Alexander A, Christian BT, et al. Physical activity and cognitive and imaging biomarkers of Alzheimer’s disease in down syndrome. Neurobiol Aging. 2021;107:118–27.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Pape SE, Baksh RA, Startin C, Hamburg S, Hithersay R, Strydom A. The association between physical activity and CAMDEX-DS changes prior to the onset of Alzheimer’s disease in Down Syndrome. J Clin Med. 2021;10(9):1882.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Ptomey LT, Szabo-Reed AN, Martin LE, Mayo MS, Washburn RA, Gorczyca AM, et al. The promotion of physical activity for the prevention of Alzheimer’s disease in adults with Down syndrome: rationale and design for a 12 month randomized trial. Contemp Clin Trials Commun. 2020;19:100607.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Deb S, Hare M, Prior L, Bhaumik S. Dementia screening questionnaire for individuals with intellectual disabilities. Br J Psychiatry. 2007;190:440–4.

    Article  PubMed  Google Scholar 

  17. Flint AC, Conell C, Ren X, Banki NM, Chan SL, Rao VA, et al. Effect of systolic and diastolic blood pressure on cardiovascular outcomes. N Engl J Med. 2019;381(3):243–51.

    Article  PubMed  Google Scholar 

  18. Kannel W, Dawber T, McGee D. Perspectives on systolic hypertension The Framingham study. Circulation. 1980;61(6):1179–82.

    Article  PubMed  CAS  Google Scholar 

  19. Fernhall B, McCubbin JA, Pitetti KH, Rintala P, Rimmer JH, Millar AL, et al. Prediction of maximal heart rate in individuals with mental retardation. Med Sci Sports Exerc. 2001;33(10):1655–60.

    Article  PubMed  CAS  Google Scholar 

  20. Choi L, Liu Z, Matthews CE, Buchowski MS. Validation of accelerometer wear and nonwear time classification algorithm. Med Sci Sports Exerc. 2011;43(2):357.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Masse LC, Fuemmeler BF, Anderson CB, Matthews CE, Trost SG, Catellier DJ, et al. Accelerometer data reduction: a comparison of four reduction algorithms on select outcome variables. Medicine & Science in Sports & Exercise. 2005;37(11 (Suppl)):S544-S54.

  22. Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc. 2008;40(1):181–8.

    Article  PubMed  Google Scholar 

  23. Matthews CE, Chen KY, Freedson PS, Buchowski MS, Beech BM, Pate RR, et al. Amount of time spent in sedentary behaviors in the United States, 2003–2004. American Journal of Epidemiology. 2008;167:875–81.

  24. Falconer DW, Cleland J, Fielding S, Reid IC. Using the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess the cognitive impact of electroconvulsive therapy on visual and visuospatial memory. Psychol Med. 2010;40(6):1017–25.

    Article  PubMed  CAS  Google Scholar 

  25. Soares FC, de Oliveira TC, de Macedo LD, Tomas AM, Picanco-Diniz DL, Bento-Torres J, et al. CANTAB object recognition and language tests to detect aging cognitive decline: an exploratory comparative study. Clin Interv Aging. 2015;10:37–48.

    PubMed  Google Scholar 

  26. Cooper S-A, Caslake M, Evans J, Hassiotis A, Jahoda A, McConnachie A, et al. Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial. Trials. 2014;15(1):202-.

  27. Vicari S, Pontillo M, Armando M. Neurodevelopmental and psychiatric issues in Down’s syndrome: assessment and intervention. Psychiatr Genet. 2013;23(3):95–107.

    Article  PubMed  CAS  Google Scholar 

  28. Égerházi A, Berecz R, Bartók E, Degrell I. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(3):746–51.

    Article  PubMed  Google Scholar 

  29. Jakobsen LH, Sorensen JM, Rask IK, Jensen BS, Kondrup J. Validation of reaction time as a measure of cognitive function and quality of life in healthy subjects and patients. Nutrition. 2011;27(5):561–70.

    Article  PubMed  Google Scholar 

  30. Deary IJ, Der G. Reaction time, age, and cognitive ability: longitudinal findings from age 16 to 63 years in representative population samples. Aging Neuropsychol Cogn. 2005;12(2):187–215.

    Article  Google Scholar 

  31. Prabu Kumar A, Omprakash A, Kuppusamy M, K.N M, B.W.C S, P.V V, et al. How does cognitive function measured by the reaction time and critical flicker fusion frequency correlate with the academic performance of students? BMC Medical Education. 2020;20(1):507.

  32. R Core Team. R: a language and environment for statistical computing [R Foundation for Statistical Computing]. Vienna, Austria; [cited 2022. Available from: https://www.R-project.org/.

  33. Beck VDY, Baynard T, Lefferts EC, Hibner BA, Fernhall B, Hilgenkamp TIM. Anthropometry does not fully explain low fitness among adults with Down syndrome. J Intellect Disabil Res. 2021;65(4):373–9.

    Article  PubMed  CAS  Google Scholar 

  34. Fernhall B, Mendonca GV, Baynard T. Reduced work capacity in individuals with Down syndrome: a consequence of autonomic dysfunction? Exerc Sport Sci Rev. 2013;41(3):138–47.

    Article  PubMed  Google Scholar 

  35. Hilgenkamp TI, Wee SO, Schroeder EC, Baynard T, Fernhall B. Peripheral blood flow regulation in response to sympathetic stimulation in individuals with Down syndrome. Artery research. 2018;24:16–21.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Rodrigues AN, Coelho LC, Goncalves WL, Gouvea SA, Vasconcellos MJ, Cunha RS, et al. Stiffness of the large arteries in individuals with and without Down syndrome. Vasc Health Risk Manag. 2011;7:375–81.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Wang C-Y, Haskell WL, Farrell SW, LaMonte MJ, Blair SN, Curtin LR, et al. Cardiorespiratory fitness levels among US adults 20–49 years of age: findings from the 1999–2004 National Health and Nutrition Examination Survey. Am J Epidemiol. 2010;171(4):426–35.

    Article  PubMed  Google Scholar 

  38. Hilgenkamp TIM, Wee SO, Schroeder EC, Baynard T, Fernhall B. Peripheral blood flow regulation in response to sympathetic stimulation in individuals with Down syndrome. Artery Res. 2018;24:16–21.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Wee SO, Pitetti KH, Goulopoulou S, Collier SR, Guerra M, Baynard T. Impact of obesity and Down syndrome on peak heart rate and aerobic capacity in youth and adults. Res Dev Disabil. 2015;36c:198–206.

  40. Palta P, Albert MS, Gottesman RF. Heart health meets cognitive health: evidence on the role of blood pressure. Lancet Neurol. 2021;20(10):854–67.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Iadecola C, Gottesman RF. Neurovascular and cognitive dysfunction in hypertension. Circ Res. 2019;124(7):1025–44.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Zigman WB. Atypical aging in Down syndrome. Dev Disabil Res Rev. 2013;18(1):51–67.

    Article  PubMed  Google Scholar 

  43. Lott IT, Head E. Dementia in Down syndrome: unique insights for Alzheimer disease research. Nat Rev Neurol. 2019;15(3):135–47.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Fernandes M, de Sousa A, Medeiros AR, Del Rosso S, Stults-Kolehmainen M, Boullosa DA. The influence of exercise and physical fitness status on attention: a systematic review. Int Rev Sport Exerc Psychol. 2019;12(1):202–34.

    Article  Google Scholar 

  45. Sandroff BM, Motl RW, DeLuca J. The influence of cognitive impairment on the fitness/cognition relationship in MS. Med Sci Sports Exerc. 2017;49(6):1184–9.

    Article  PubMed  Google Scholar 

  46. Etnier JL, Caselli RJ, Reiman EM, Alexander GE, Sibley BA, Tessier D, et al. Cognitive performance in older women relative to ApoE-ε4 genotype and aerobic fitness. Med Sci Sports Exerc. 2007;39(1):199–207.

    Article  PubMed  CAS  Google Scholar 

  47. Hayes SM, Forman DE, Verfaellie M. Cardiorespiratory fitness is associated with cognitive performance in older but not younger adults. J Gerontol B Psychol Sci Soc Sci. 2016;71(3):474–82.

    Article  PubMed  Google Scholar 

  48. Dougherty RJ, Schultz SA, Boots EA, Ellingson LD, Meyer JD, Van Riper S, et al. Relationships between cardiorespiratory fitness, hippocampal volume, and episodic memory in a population at risk for Alzheimer’s disease. Brain and behavior. 2017;7(3):e00625.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Ptomey LT, Szabo AN, Willis EA, Gorczyca AM, Greene JL, Danon JC, et al. Changes in cognitive function after a 12-week exercise intervention in adults with Down syndrome. Disabil Health J. 2018;11(3):486–90.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Taylor AW. Physiology of exercise and healthy aging: human kinetics; 2022.

  51. Handen BL, Lott IT, Christian BT, Schupf N, OBryant S, Mapstone M, et al. The Alzheimer's biomarker consortium‐Down Syndrome: rationale and methodology. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2020;12(1):e12065.

  52. Chen CC, Ringenbach S. Dose–response relationship between intensity of exercise and cognitive performance in individuals with Down syndrome: a preliminary study. J Intellect Disabil Res. 2016;60(6):606–14.

    Article  PubMed  Google Scholar 

  53. Chen CC, Ringenbach S. The effect of acute exercise on the performance of verbal fluency in adolescents and young adults with Down syndrome: a pilot study. J Intellect Disabil Res. 2019;63(6):614–23.

    Article  PubMed  Google Scholar 

  54. Ringenbach SD, Albert AR, Chen C-C, Alberts JL. Acute bouts of assisted cycling improves cognitive and upper extremity movement functions in adolescents with Down syndrome. Ment Retard. 2014;52(2):124–35.

    Google Scholar 

Download references

Acknowledgements

We would like to acknowledge Ms. Annie Rice for her work in data collection.

Funding

This trial was funded by the National Institute of Aging (AG063909) and supported by the Kansas Center for Metabolism and Obesity Research (P20GM144269), and the funder did not participate in the work. Additionally, BC Helsel was supported by a Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS) awarded to the University of Kansas for Frontiers: University of Kansas Clinical and Translational Science Institute (grant no.TL1TR002368).

Author information

Author notes

  1. Lauren Frank and Brian Helsel worked as and are submitting and co-first authors.

Authors and Affiliations

  1. School of Medicine, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA

    Lauren Frank & Danica Dodd

  2. Department of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Mail Stop 1073, Kansas City, KS, 66160, USA

    Lauren Frank, Danica Dodd, Amy E. Bodde, Jessica C. Danon, Joseph R. Sherman, Amanda Szabo-Reed, Richard A. Washburn, Joseph E. Donnelly & Lauren T. Ptomey

  3. Department of Neurology, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA

    Brian Helsel

  4. Ward Family Heart Center, Children’s Mercy Kansas City, Kansas City, MO, USA

    Daniel E. Forsha

Authors
  1. Lauren Frank
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian Helsel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Danica Dodd
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amy E. Bodde
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jessica C. Danon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joseph R. Sherman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Daniel E. Forsha
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Amanda Szabo-Reed
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Richard A. Washburn
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Joseph E. Donnelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Lauren T. Ptomey
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Drs. Ptomey, Washburn, Szabo-Reed, Forsha, and Donnelly conceptualized and designed the study, coordinated and supervised the data collection, drafted the initial manuscript, and reviewed and revised the manuscript. Ms. Frank and Dr. Helsel oversaw the initial analysis, drafted the initial manuscript, and reviewed and revised the manuscript. Dr. Bodde, Ms. Dodd, Mr. Sherman, and Ms. Danon designed the data collection instruments, collected the data, carried out the initial analyses, and reviewed and revised the manuscript. All authors approved the final manuscript as submitted and agreed to be accountable for all aspects of the work.

Corresponding author

Correspondence to Lauren T. Ptomey.

Ethics declarations

Ethics approval and consent participate

This trial was approved by the Institutional Review Board at the University of Kansas Medical Center. All participants provide written consent or legal guardian consent and written assent.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Frank, L., Helsel, B., Dodd, D. et al. The association between cardiovascular health and cognition in adults with Down syndrome. J Neurodevelop Disord 15, 43 (2023). https://doi.org/10.1186/s11689-023-09510-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s11689-023-09510-z

Keywords

Journal of Neurodevelopmental Disorders

ISSN: 1866-1955

Contact us